Securus Technologies Continues To Improve Efficiency With Latest Acquisition

Carrollton, Texas-based Securus Technologies recently announced that the company has acquired payment systems solutions company GovPayNet. The acquisition is part of Securus Technologies’ desire to increase its payment solutions business. With the added infrastructure and technology, Securus estimates that its payment solutions arm will now be able to process over 40 million payments annually. This further diversifies Securus’ portfolio of products that service government entities and increases its already large market share. CEO Bob Pickens is excited to expand into additional government payment processing segment with the addition of GovPayNet.


GovPayNet is a leading payment processing company that specializes in credit and debit transactions in various national, state, and local governments. They service of 2,300 government agencies across the United States and has been in business since 1997. Securus Technologies services over 3,500 government and corrections agencies in the United States. A large segment of their business services over 1.2 million inmates, providing calling card and payment services for those incarcerated. The company also provides information management, inmate self-service, biometric services, and public information services in its portfolio of products. The acquisition will help better align the company with services it already provides, and create higher efficiency across its products.


Dr. Mark Holterman Lends Support To Ill Children In Need

There are many ways to show generosity in the world. Dr. Mark Holterman found his way by supporting a bevy of health-related charities. One of the charities that Holterman lends his support to is the International Pediatric Specialists Alliance for the Children of Vietnam. IPSAC-VN brings surgical advances to medical schools and hospitals to aid sick children. Those who wish to offer support can do so by donating or lending their volunteer services.

Volunteer services are needed and sought after by IPSAC-VN. It’s important to note that there are minimum requirements to meet in order to offer volunteer support. Volunteers must have a valid passport that will not expire under six months after a scheduled visit. Volunteers must also provide a copy of their medical license and a complete CV. Learn more about Dr. Mark Holterman at OSF Healthcare.

Unfortunately, many children that IPSAC-VN caters to must undergo surgery. The list includes: tumor removal, organ transplants, brain surgery, repairing spinal abnormalities, fetal development correction, and more.

Dr. Mark Holterman has made it a mission to give these children the aid they need. Holterman is a professor at the University of Illinois College of Medicine. He’s held the position since 2011. Holterman is also the attending pediatric surgeon at the St. Francis Medical Center and Advocate Christ Children’s Hospital. Visit to view Dr. Mark Holterman’s profile.

It doesn’t stop there for Holterman. As the CEO of Mariam Global Health, he has done extensive research on promising medical technologies such as stem cell regeneration therapy. Research on new breakthroughs for cancer treatment and obesity management is also on Holterman’s watch. Clinical trials of stem cell therapies have proven to be successes. This includes creating a synthetic trachea from the bone marrow of a patient. This can be used to replace a damaged trachea. In addition to these advancements, immunosuppression treatments have also been used for those who suffer from diabetes.


Oncologist Dr. Mikhail Blagosklonny Takes On Both Cancer And Aging

Many doctors and researchers dedicate their lives to just one field of research. One renowned Oncologist, however, is making his name known for research in both cancer and anti-aging research. For Dr. Mikhail Blagosklonny, working on treatments for both cancer and the effects of aging is a passion that has spanned for decades.

Dr. Blagosklonny’s research into both cancer and anti-aging can be traced back to his work with the cancer treatment drug Rapamycin. Also known as Sirolimus, this drug is used to help prevent organ transplant rejection. Further research by Dr. Blagosklonny has shown that Rapamycin has incredible immunosuppressive and antiproliferative properties that can be used in anti-aging treatment. Read Mikhail’s plans for Oncology on

Dr. Blagosklonny’s research has shown that Rapamycin can be a useful treatment in the field of anti-aging and has advocated for the wider use of the drug. The Oncologist tested the drug on aging mice and found that the mice were able to deal with diseases such as tuberculosis.

Human tests on Rapamycin revealed immunological rejuvenation on a set of elderly patients. The drug was given to the patients before they received an influenza vaccination. While there is not yet conclusive proof that Rapamycin can increase human longevity, Dr. Blagosklonny advocates continuing research of the drug on a wide group of human test subjects.

Mikhail Blagosklonny’s research centers around his belief that cancer and anti-aging are both intertwined. And by using cancer drugs to treat aging, the population can see an overall increase in lifespan while seeing a decrease in cancer rates.

Learn more:

This is what makes Rapamycin a big focus of Mikhail Blagosklonny’s research. The drug is one of the only known that can both fight cancer and aging. Some of the other impacts of Rapamycin on the human body include immunosuppressant properties, treatment for patients with the hemolytic-uremic syndrome, treatment of Lymphangioleiomyomatosis, coronary stent coating, treatment of tuberous sclerosis complex, treatment of Alzheimer’s disease and treatment of muscular dystrophy.

Dr. Mikhail Blagosklonny received his medical doctorate degree in internal medicine from the First Pavlov State Medical University of St. Petersburg. He also received a doctorate in experimental medicine and cardiology from the same university. Later he became an associate professor of medicine at New York Medical College in Valhalla, NY. Dr. Blagosklonny left that position a few years later to become a senior scientist at Ordway Research Institute. In 2009, Dr. Blagosklonny became a professor of oncology at Roswell Park Cancer Institute. He held that position until 2016.

Today, Dr. Blagosklonny is the foremost advocate for using cancer drugs for anti-aging treatment. The Oncologist’s tireless work has impacted thousands of people with the hope that millions can find an affordable and effective treatment for both cancer and diseases related to aging. Know more about Mikhail at Philly Purge.

Doubled Schedule and Efforts of Oncotarget

Oncotarget is one of the largest online medical journals written in English. It has a focus primarily on oncology, but in recent years Oncotarget has started publishing about several other disciplines in the biomedical field. Some of those include Pathology, Immunology, Chromosomes, and more.

Over the year, Oncotarget has been edited and reviewed by peers. Having other scientists and medical experts review the journal, and its publications make it more accurate and trustworthy. The numbers and other data in the journal are also coordinated with archives and indexes to assure accuracy. It is a priority for Oncotarget to provide reliable information for its readers- both practitioner and interested people of the general public. Visit Soundcloud to listen an audio podcast of Oncotarget.

Over the years, Oncotarget has been publishing one every week. A couple of months ago, the online biomedical journal announced that they would be doubling their output n order to provide more information for their audience. The journal will also be available in a variety of archives, including some of the most prestigious ones.

Oncotarget is peer-reviewed by dozens of scientists and biomedical experts in several disciplines. The online journal is continually trying to expand upon its content which will help them achieved their doubled schedule. The two Editors in Chief of Oncotarget are oncologists who also specialize in cardiology and aging.

Learn more:

Dr. Andrei Gudkov is serving at the Roswell Park Cancer Institut. He conducts research in cardiology and oncology and teaches as a professor at a local university

Dr. Mikhail Blakosklonny used to work at the Roswell Park Cancer Institute as well. He was a senior scientist from 2009 till 2016. While he was working at the Institute, Dr. Mikhail Blagosklonny was also an editor for two other online medical journals called Cell Cycle and Aging. He is focused on his work as an editor.

Before assuming a position at the Rowell Park Cancer Institute, Dr. Mikhail Bagosklonny worked as a professor of medicine at a local college and then another research institute in New York. He has also made many contributions to a variety of journals and other medical publication detailing his progress in his research. Visit Oncotarget’s profile page at

Brown Agency Helps Models Advance Their Careers

Wilhelmina Austin has relaunched as The Brown Agency after acquiring Heyman Talent-South. This means that two of the largest talent agencies in the regions have come together to provide a wealth of strategies and tactics that will make The Brown Agency Austin’s only full-service agency. This is also one of the few businesses of its kind in the state of Texas.


Justin Brown is running the agency, and helped to launched Wilhelmina Austin in 2010. The agency has become one of the foremost agencies for models in central Texas. During the last few years, Heyman Talent-South has expanded to be a successful acting agent, and one of the best in the city of Austin. The combination of the two agencies and the launch of of a new company gives clients a varied portfolio of experienced talent and provides clients with more opportunities in Austin and the U.S.


The Brown Agency is headquartered in Austin but will also have a Dallas office and representation in Los Angeles. Justin Brown, who was formerly the head of Wilhelmina Austin will be the president and CEO of The Brown Agency. Heyman Talent-South founder Michael B. Bonnée will also provide his experience and expertise to clients who are interested in the theatrical division of The Brown Agency.


Brown shares that the merger with Heyman Talent-South to become a full-serve agency is a very important part of the business’ strategy for growth and dedication for effectively serving clients. He also asserts that both agencies are proud to select the best talent and prepare them for work in a larger market by developing their skills and professionalism.


Bonnée shares that he is excited to partner with The Brown Agency and is confident that the talent and experience that the professionals from both companies posses will make this an exciting opportunity for both staff and talent.


The financial details of the merger agreement were not made available to the public. An official celebration and introduction of The Brown Agency was planned for December.


The Brown Agency is a model and commercial talent agency servicing clients in central Texas by giving models and actors a number of talent options and exposure to platforms that will help them grow their careers. For more information, visit and their Instagram page.


Glen Wakeman: Giving Points on Being a Successful Businessman

Starting a business requires capital, skills, and knowledge about how it works. But for Glen Wakeman, aside from these three major requirements in opening a small company, he also added five points that an entrepreneur must remember to succeed in his chosen career. Glen Wakeman is an American financial executive, who is working with different businesses and companies for more than two decades. He is helping them develop their business models and introducing new approaches and methods for success, and he also manages investments from his clients. According to Glen Wakeman, every business must focus on five major points: leadership, human capital, human capital, risk management, and governance. Mastering these five points would ensure that a business would thrive. View Glen Wakeman’s profile

Before being a financial executive, Glen Wakeman worked with several companies in the past. His first job was with GE Capital, where he worked for more than 20 years. He was assigned to different departments while working for GE Capital, and he worked hard until he got promoted to become the company’s CEO for their Latin American arm. He is recognized as a great leader because he managed to innovate and develop the approach used by the business, and it resulted in the rise of their profits.

Learn more:


Glen Wakeman established Nova Four to provide financial assistance and management services to small businesses. He is also giving them tips on how to reach a more significant market, and how they can take advantage of a widely connected world. Glen Wakeman and his company are one of the most reliable and trustworthy firms helping small businesses, and their services are becoming in demand as more people are sharing their positive experiences working with Nova Four. Follow Glen Wakeman’s profile on Twitter.